Login to Your Account



Pharma: Other News To Note


Monday, May 20, 2013
• Mylan Inc., of Pittsburgh, said its subsidiary Mylan Pharmaceuticals Inc. has shipped Fenofibrate Tablets, 48 mg and 145 mg. Mylan Pharmaceuticals received final approval from the FDA for its abbreviated new drug application for this product, which is the generic version of Tricor (fenofibrate, AbbVie).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription